XML 32 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Cash flows from operating activities:    
Net income $ 33,341 $ 15,422
Adjustments to reconcile net income to cash provided by (used in) operating activities:    
Depreciation and amortization expense 4,001 3,801
Deferred federal income taxes 2,596 445
Investment gains, net (17,412) (2,678)
Share-based payments expense 514 37
Change in ceded unearned premiums (31,015) (23,244)
Change in premiums receivable (20,802) (6,993)
Change in accounts receivable (27) 49
Change in deferred policy acquisition costs (7,613) 2,852
Change in unpaid losses and loss adjustment expenses 38,049 3,716
Change in unearned premiums 82,005 20,747
Change in reinsurance recoverable (61,523) (43,004)
Change in reinsurance balances payable (5,529) 3,343
Change in current federal income tax payable 676 7,676
Change in all other liabilities 677 (4,429)
Change in all other assets 4,962 3,277
Net cash provided by (used in) operating activities 22,900 (18,983)
Cash flows from investing activities:    
Purchases of property and equipment (3,688) (1,530)
Purchases of investment securities (184,689) (160,147)
Maturities, sales and redemptions of investment securities 171,587 177,693
Net cash (used in ) provided by investing activities (16,790) 16,016
Cash flows from financing activities:    
Proceeds from exercise of employee stock options 1,520 242
Payment of revolving credit facility (30,000)  
Payment of debt issuance costs (979)  
Proceeds from senior unsecured note offering 50,000  
Purchase of treasury shares (1,380) (1,464)
Net cash provided by (used in) financing activities 19,161 (1,222)
Increase (decrease) in cash and cash equivalents and restricted cash 25,271 (4,189)
Cash and cash equivalents and restricted cash at beginning of period 40,471 67,633
Cash and cash equivalents and restricted cash at end of period $ 65,742 $ 63,444